Home LiteratureArticle Details
PMID: 15866758 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression.

Environmental health perspectives ·Vol. 113 ·No. 5 ·2005-05-00 ·Pages 527-31

Aldridge JE, Levin ED, Seidler FJ, Slotkin TA

Abstract

Developmental exposure to chlorpyrifos (CPF) causes persistent changes in serotonergic (5HT) systems. We administered 1 mg/kg/day CPF to rats on postnatal days 1-4, a regimen below the threshold for systemic toxicity. When tested in adulthood, CPF-exposed animals showed abnormalities in behavioral tests that involve 5HT mechanisms. In the elevated plus maze, males treated with CPF spent more time in the open arms, an effect seen with 5HT deficiencies in animal models of depression. Similarly, in an anhedonia test, the CPF-exposed group showed a decreased preference for chocolate milk versus water. Developmental CPF exposure also has lasting effects on cognitive function. We replicated our earlier finding that developmental CPF exposure ablates the normal sex differences in 16-arm radial maze learning and memory: during acquisition training, control male rats typically perform more accurately than do control females, but CPF treatment eliminated this normal sex difference. Females exposed to CPF showed a reduction in working and reference memory errors down to the rate of control males. Conversely, CPF-exposed males exhibited an increase in working and reference memory errors. After radial-arm acquisition training, we assessed the role of 5HT by challenging the animals with the 5HT2 receptor antagonist ketanserin. Ketanserin did not affect performance in controls but elicited dose-dependent increases in working and reference memory errors in the CPF group, indicating an abnormal dependence on 5HT systems. Our results indicate that neonatal CPF exposures, classically thought to be subtoxic, produce lasting changes in 5HT-related behaviors that resemble animal models of depression.

MeSH Terms
Animals Animals, Newborn Behavior, Animal Chlorpyrifos/administration & dosage,toxicity Cognition Disorders/chemically induced Depression/physiopathology Disease Models, Animal Female Injections, Subcutaneous Insecticides/administration & dosage,toxicity Male Maze Learning Memory Memory Disorders/chemically induced Random Allocation Rats/growth & development Rats, Sprague-Dawley Serotonin/physiology
Chemicals
Insecticides Serotonin Chlorpyrifos
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Aldridge Justin E
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27701, USA.
Levin Edward D
Seidler Frederic J
Slotkin Theodore A
References (53)
53 references, click to expand
  1. 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.
    J Pharmacol Exp Ther. 1998 Aug;286(2):913-24 PMID: 9694950
  2. Chlorpyrifos exposure during neurulation: cholinergic synaptic dysfunction and cellular alterations in brain regions at adolescence and adulthood.
    Brain Res Dev Brain Res. 2004 Jan 31;148(1):43-52 PMID: 14757517
  3. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade.
    Toxicol Appl Pharmacol. 1997 Jul;145(1):158-74 PMID: 9221834
  4. Endocrine changes in patients with acute organophosphate poisoning.
    Hum Exp Toxicol. 1999 Oct;18(10):598-601 PMID: 10557009
  5. Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats.
    Pharmacol Biochem Behav. 2004 Jan;77(1):21-8 PMID: 14724038
  6. Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure.
    Brain Res Dev Brain Res. 2002 Feb 28;133(2):163-73 PMID: 11882346
  7. Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?
    Int J Neurosci. 2004 Jun;114(6):593-611 PMID: 15204055
  8. Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals.
    Drug Metab Dispos. 2003 Apr;31(4):384-91 PMID: 12642463
  9. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro.
    Toxicol Appl Pharmacol. 2002 Feb 15;179(1):1-12 PMID: 11884232
  10. Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling.
    Environ Health Perspect. 2004 Feb;112(2):170-8 PMID: 14754571
  11. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations.
    Neurotoxicol Teratol. 2002 Nov-Dec;24(6):733-41 PMID: 12460655
  12. Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos.
    Brain Res Dev Brain Res. 2001 Sep 23;130(1):65-72 PMID: 11557094
  13. Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat.
    Psychopharmacology (Berl). 2000 May;150(1):52-60 PMID: 10867976
  14. Organophosphorus pesticides: do they all have the same mechanism of toxicity?
    J Toxicol Environ Health B Crit Rev. 1999 Apr-Jun;2(2):161-81 PMID: 10230392
  15. Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats.
    J Pharmacol Exp Ther. 1999 Apr;289(1):334-45 PMID: 10087022
  16. Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat.
    Int Rev Neurobiol. 1981;22:251-86 PMID: 7024168
  17. Prevalence of fetal exposure to environmental toxins as determined by meconium analysis.
    Neurotoxicology. 2002 Sep;23(3):329-39 PMID: 12389578
  18. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates.
    Toxicol Mech Methods. 2004;14(3):103-43 PMID: 20021140
  19. Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period?
    Environ Health Perspect. 2002 Nov;110(11):1097-103 PMID: 12417480
  20. A review of the pharmacological and clinical profile of mirtazapine.
    CNS Drug Rev. 2001 Fall;7(3):249-64 PMID: 11607047
  21. Determination of the reference dose for chlorpyrifos: proceedings of an expert panel.
    J Toxicol Environ Health B Crit Rev. 1999 Jul-Sep;2(3):211-55 PMID: 10429680
  22. Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons.
    Toxicol Appl Pharmacol. 2002 Jul 15;182(2):176-85 PMID: 12140181
  23. Developmental neurotoxicity elicited by prenatal or postnatal chlorpyrifos exposure: effects on neurospecific proteins indicate changing vulnerabilities.
    Environ Health Perspect. 2003 Mar;111(3):297-303 PMID: 12611658
  24. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways.
    Brain Res Dev Brain Res. 1999 Aug 5;116(1):9-20 PMID: 10446342
  25. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling.
    Environ Health Perspect. 2004 Feb;112(2):148-55 PMID: 14754568
  26. Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood.
    Environ Health Perspect. 2003 Apr;111(4):536-44 PMID: 12676612
  27. Childhood obesity is associated with maternal smoking in pregnancy.
    Eur J Pediatr. 2002 Aug;161(8):445-8 PMID: 12172830
  28. Common mechanism of toxicity: a case study of organophosphorus pesticides.
    Toxicol Sci. 1998 Jan;41(1):8-20 PMID: 9520337
  29. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms.
    Toxicol Appl Pharmacol. 1995 Sep;134(1):53-62 PMID: 7545834
  30. Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study.
    Eur Neuropsychopharmacol. 2003 Mar;13(2):123-8 PMID: 12650957
  31. Vulnerable processes of nervous system development: a review of markers and methods.
    Neurotoxicology. 2000 Feb-Apr;21(1-2):15-36 PMID: 10794382
  32. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
    Pharmacol Biochem Behav. 1999 Jun;63(2):333-8 PMID: 10371664
  33. Persistent cholinergic presynaptic deficits after neonatal chlorpyrifos exposure.
    Brain Res. 2001 Jun 1;902(2):229-43 PMID: 11384617
  34. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
    Eur J Pharmacol. 1999 Jan 8;364(2-3):123-32 PMID: 9932714
  35. Molecular aspects of sexual differentiation of the rodent brain.
    Psychoneuroendocrinology. 1994;19(5-7):415-27 PMID: 7938343
  36. Chlorpyrifos exposure during a critical neonatal period elicits gender-selective deficits in the development of coordination skills and locomotor activity.
    Brain Res Dev Brain Res. 2000 Jun 30;121(2):179-87 PMID: 10876030
  37. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods.
    Environ Health Perspect. 2003 Nov;111(14):1736-43 PMID: 14594624
  38. Persistent behavioral consequences of neonatal chlorpyrifos exposure in rats.
    Brain Res Dev Brain Res. 2001 Sep 23;130(1):83-9 PMID: 11557096
  39. Anhedonia, self-experience in schizophrenia, and implications for treatment.
    Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S176-80 PMID: 14677076
  40. Cholinesterase and self-reported pesticide exposure among pregnant women.
    Arch Environ Health. 1993 Sep-Oct;48(5):348-52 PMID: 8215600
  41. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression.
    Physiol Behav. 1993 Dec;54(6):1215-20 PMID: 8295967
  42. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets.
    Chem Res Toxicol. 2004 Aug;17(8):983-98 PMID: 15310231
  43. Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures.
    J Toxicol Environ Health B Crit Rev. 1999 Jul-Sep;2(3):257-79 PMID: 10429681
  44. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates.
    Toxicol Appl Pharmacol. 2004 Jul 15;198(2):132-51 PMID: 15236950
  45. (+)-S-20499 -- a potential antidepressant? A behavioural and neurochemical investigation in the olfactory bulbectomised rat.
    Eur Neuropsychopharmacol. 1999 Jan;9(1-2):21-7 PMID: 10082224
  46. Maternal smoking during pregnancy and childhood obesity.
    Am J Epidemiol. 2002 Nov 15;156(10):954-61 PMID: 12419768
  47. Developmental cholinotoxicants: nicotine and chlorpyrifos.
    Environ Health Perspect. 1999 Feb;107 Suppl 1:71-80 PMID: 10229709
  48. Behavioral alterations in adolescent and adult rats caused by a brief subtoxic exposure to chlorpyrifos during neurulation.
    Neurotoxicol Teratol. 2004 Jan-Feb;26(1):95-101 PMID: 15001218
  49. Animal models of depression: parallels and correlates to severe depression in humans.
    Biol Psychiatry. 1985 Jul;20(7):764-84 PMID: 2860930
  50. Critical periods for chlorpyrifos-induced developmental neurotoxicity: alterations in adenylyl cyclase signaling in adult rat brain regions after gestational or neonatal exposure.
    Environ Health Perspect. 2004 Mar;112(3):295-301 PMID: 14998743
  51. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors.
    Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):104-16 PMID: 15469887
  52. The olfactory bulbectomized rat as a model of depression: an update.
    Pharmacol Ther. 1997;74(3):299-316 PMID: 9352586
  53. Accumulation of chlorpyrifos on residential surfaces and toys accessible to children.
    Environ Health Perspect. 1998 Jan;106(1):9-16 PMID: 9417768
Article Info
Journal
Environmental health perspectives
Abbr.
Environ Health Perspect
ISSN
0091-6765
Published
2005-05-00
Pages
527-31
Language
English
Region
United States
NLM ID
0330411
PMCID
PMC1257542
Subset
IM
Grants
NIEHS NIH HHS · ES 07031 · United States
NIEHS NIH HHS · ES 10356 · United States
NIEHS NIH HHS · ES 10387 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]